Josée Zijlstra

34PUBLICATIONS
142CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Animal physiology - cell
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Jun 30, 2026
Validation of the newly introduced Deauville Score 5a in patients treated for advanced-stage classic Hodgkin Lymphoma.

|Feb 14, 2026
A Lesion-adaptive Segmentation Approach for Tumor Delineation on FDG PET/CT in Diffuse Large B-cell Lymphoma Patients.

Gerben J C Zwezerijnen, Martijn W Heymans, Danielle van Assema

|Feb 09, 2026
MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assay.

Jan-Michel Heger, Julia Mattlener, Helen Kaul

|Sep 13, 2025
Predicting Absolute Risk of First Relapse in Classical Hodgkin Lymphoma by Incorporating Contemporary Treatment Effects.

Shahin Roshani, Flora E van Leeuwen, Sara Rossetti

|Aug 18, 2025
Can we obtain prognostic information from healthy tissue uptake and volume in baseline 18F-FDG PET/CT imaging in diffuse large B-cell lymphoma?

Nienke R Gerards, Sanne E Wiegers, Anne L Bes

|Jun 05, 2025
Attendance at survivorship clinics in relation to Hodgkin lymphoma survivor and treatment characteristics.

Eline M J Lammers, Berthe M P Aleman, Michael Schaapveld

Pageof 6

Frequent Collaborators

14 joint publications

Gerben Jc Zwezerijnen

12 joint publications

Pieternella J Lugtenburg

11 joint publications

Jakoba J Eertink

10 joint publications

Sanne E Wiegers